Our Clients

Aclipse Therapeutics

Aclipse Therapeutics

(Private)

Aethlon Medical

Aethlon Medical

(NASDAQ: AEMD)

Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc.

(NYSE: ARE)

BeiGene, Ltd.

BeiGene, Ltd.

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235)

Berkshire Biomedical, LLC

Berkshire Biomedical, LLC

(Private)

Ceramedix Holding, LLC

Ceramedix Holding, LLC

(Private)

Cerus Endovascular Ltd.

Cerus Endovascular Ltd.

(NASDAQ: CERS)

DNB//Back Bay

DNB//Back Bay

(Private)

Hansa Biopharma AB

Hansa Biopharma AB

(OMX: HNSA)

Immunic, Inc.

Immunic, Inc.

(NASDAQ: IMUX)

Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc.

(Private)

Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc.

(NASDAQ: INTS)

IVERIC Bio, Inc.

IVERIC Bio, Inc.

(NASDAQ: ISEE)

LTR Pharma Ltd

LTR Pharma Ltd

(ASX: LTP)

Lutris Pharma

Lutris Pharma

(Private)

MaaT Pharma

MaaT Pharma

(EURONEXT: MAAT)

MetaVia

MetaVia

(NASDAQ: MTVA)

miRecule, Inc.

miRecule, Inc.

(Private)

Molecure S.A.

Molecure S.A.

(WSE: MOC)

Rejuvitas, Inc.

Rejuvitas, Inc.

(Private)

RenBio, Inc.

RenBio, Inc.

(Private)

Repligen Corporation

Repligen Corporation

(NASDAQ: RGEN)

Reshape Lifesciences Inc.

Reshape Lifesciences Inc.

(NASDAQ: RSLS)

Semler Scientific, Inc.

Semler Scientific, Inc.

(NASDAQ: SMLR)

ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc.

(NASDAQ: THMO)